VKH
RKDA icon

Virtu KCG Holdings’s Arcadia Biosciences RKDA Stock Holding History

Virtu KCG Holdings’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$22K Buy
60
+47
+362% +$26.2K ﹤0.01% 2714
2017
Q1 		$7K Sell
13
-45
-78% -$32.3K ﹤0.01% 3034
2016
Q4 		$43K Buy
+58
New +$65.9K ﹤0.01% 3122

Other funds holding RKDA

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Virtu KCG Holdings's RKDA Position: Q2 2017 in Review

Virtu KCG Holdings increased its Arcadia Biosciences (RKDA) stake by 362% in Q2 2017, buying an estimated $26.2K and bringing the position to 60 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #2714.

Virtu KCG Holdings first reported a position in RKDA in Q4 2016 and has held it in 3 quarters since. The position peaked at $43K in Q4 2016. 15 funds tracked by Wall St. Rank hold RKDA as of Q2 2017.

  • Virtu KCG Holdings held 60 shares of Arcadia Biosciences worth $22K as of Q2 2017.
  • Virtu KCG Holdings bought 47 Arcadia Biosciences shares in Q2 2017, an estimated $26.2K.
  • Arcadia Biosciences made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2714 holding.
  • Virtu KCG Holdings first reported a position in Arcadia Biosciences in Q4 2016 and has held it in 3 quarters since.
  • Virtu KCG Holdings's Arcadia Biosciences position peaked at $43K in Q4 2016.
  • 15 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.